Dr. Peter Tod Magnusson, MD

Dr. Magnusson practices at Enloe Health in Chico, California, part of Enloe Health.

Dr. Magnusson's NPI, 1164595914, was assigned on November 16, 2006. Dr. Magnusson graduated from University of Illinois College of Medicine - Chicago in 1970. Dr. Magnusson holds California license G21743.

Dr. Magnusson's primary practice is Enloe Health, at 1531 Esplanade, Chico, CA 95926 in Butte County. The practice phone is (530) 332-7300.

Dr. Magnusson's primary practice is Enloe Health in Chico, California, part of Enloe Health. Dr. Magnusson is also affiliated with Oroville Hospital. The medical group on file is Chico Hospitalist Group. Dmand AI also links Dr. Magnusson to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Magnusson practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Magnusson's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Magnusson is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Magnusson is licensed in California.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, deep vein thrombosis (DVT), endocarditis and heart blockage among the conditions Dr. Magnusson treats.

CMS data shows 2,224 Medicare services from Dr. Magnusson across 13 procedure codes in 2024, for 874 Medicare patients. Medicare paid $128,469 for them.

CMS counts 874 Medicare patients who saw Dr. Magnusson in 2024. The largest group is 75 to 84, with 410 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Magnusson's median patient age at 79, with 45% women.

In 2024, Dr. Magnusson wrote 3,996 Medicare Part D claims for 609 patients. 86% of them were for generic drugs. CMS names the drug for 3,758 of them, across 43 drugs with 11 or more claims each, at $615,707 in total drug cost. In 2023, CMS named 3,473 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Magnusson for performance year 2024, reported as part of a group. Dr. Magnusson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 39 papers to Dr. Magnusson, published from 2013 to 2023. 2020 was the busiest year, with 7. The most frequent topics are Blood Pressure, COVID-19 and Heart Failure. Dr. Magnusson has published most often in Cureus. Dr. Magnusson's most frequent co-authors are Joseph Vincent Pergolizzi, MD, Rohit Nalamasu, DO and Paul Jordan Christo, MD.

Dmand AI links Dr. Magnusson to 4 clinical trials. Conditions studied include Aortic Stenosis, Subvalvular, Cardiomyopathy, Hypertrophic and Stroke. Region Gävleborg sponsors the most, 2.

CMS Open Payments shows 76 general payments to Dr. Magnusson from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Boston Scientific Corporation paid the most, $1,013.

Dmand AI lists 2 awards for Dr. Magnusson, most recently CMS Stage 1 EHR in 2013.

Dr. Magnusson graduated from University of Illinois College of Medicine - Chicago in 1970. Dr. Magnusson is a member of ACC.

Dr. Magnusson is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.